image credit: Unsplash

FDA panel to discuss boosters as Moderna seeks OK for additional shot

September 2, 2021


Moderna’s submission is a significant step toward a broader authorization for booster shots; one that Pfizer took on Aug. 25. As the delta variant spreads across the country, accounting for over 90% of new coronavirus infections, public health officials have pitched boosters as a way to maintain high protection against COVID-19. For some experts, however, the case isn’t as clear-cut when it comes to healthy adults.

Read More on Biopharma Dive